Skip to main content
TipRanks
Go Ultimate75% OFF

KUKJE PHARMA Co., Ltd. (002720) Stock Statistics & Valuation Metrics

Total Valuation

KUKJE PHARMA Co., Ltd. has a market cap or net worth of KRW 60.68B. The enterprise value is KRW 85.86B.

Market Cap
KRW 60.68B
Enterprise Value
KRW 85.86B

Share Statistics

KUKJE PHARMA Co., Ltd. has 21,159,832 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
21,159,832
Owned by Insiders
―
Owned by Institutions
0.02%

Financial Efficiency

KUKJE PHARMA Co., Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.45%.

Return on Equity (ROE)
0.06
Return on Assets (ROA)
0.03
Return on Invested Capital (ROIC)
3.45%
Return on Capital Employed (ROCE)
0.05
Revenue Per Employee
645.21M
Profits Per Employee
20.95M
Employee Count
272
Asset Turnover
0.92
Inventory Turnover
3.19

Valuation Ratios

The current PE Ratio of KUKJE PHARMA Co., Ltd. is 17.79. KUKJE PHARMA Co., Ltd.’s PEG ratio is -0.34.

PE Ratio
17.79
PS Ratio
0.34
PB Ratio
0.63
Price to FCF
-15.76
Price to Operating Cash Flow
81.29
PEG Ratio
-0.34

Income Statement

In the last 12 months, KUKJE PHARMA Co., Ltd. had revenue of 175.50B and earned 5.70B in profits. Earnings per share was 279.51.

Revenue
175.50B
Gross Profit
92.97B
Operating Income
6.18B
Pretax Income
6.44B
Net Income
5.70B
EBITDA
9.41B
Earnings Per Share (EPS)
279.51

Cash Flow

In the last 12 months, operating cash flow was 6.69B and capital expenditures -4.37B, giving a free cash flow of 2.32B billion.

Operating Cash Flow
6.69B
Free Cash Flow
2.32B
Free Cash Flow per Share
-189.06

Dividends & Yields

KUKJE PHARMA Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of 1.01%

Dividend Per Share
―
Dividend Yield
1.01%
Payout Ratio
N/A
Free Cash Flow Yield
-6.34%
Earnings Yield
5.62%

Stock Price Statistics

Beta
-0.05
52-Week Price Change
-31.73%
50-Day Moving Average
3492.60
200-Day Moving Average
3905.08
Relative Strength Index (RSI)
32.62
Average Volume (3m)
1.99M

Important Dates

KUKJE PHARMA Co., Ltd. upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 16, 2026
Next Earnings Date
Mar 25, 2027
Ex-Dividend Date
―

Financial Position

KUKJE PHARMA Co., Ltd. as a current ratio of 1.09, with Debt / Equity ratio of 31.12%

Current Ratio
1.09
Quick Ratio
0.67
Debt to Market Cap
0.34
Net Debt to EBITDA
2.09
Interest Coverage Ratio
6.81

Taxes

In the past 12 months, KUKJE PHARMA Co., Ltd. has paid 738.54M in taxes.

Income Tax
738.54M
Effective Tax Rate
0.11

Enterprise Valuation

KUKJE PHARMA Co., Ltd. EV to EBITDA ratio is 11.11, with an EV/FCF ratio of -20.37.

EV to Sales
0.44
EV to EBITDA
11.11
EV to Free Cash Flow
-20.37
EV to Operating Cash Flow
105.07

Balance Sheet

KUKJE PHARMA Co., Ltd. has KRW 15.72B in cash and marketable securities with KRW 31.39B in debt, giving a net cash position of -KRW 15.67B billion.

Cash & Marketable Securities
KRW 15.72B
Total Debt
KRW 31.39B
Net Cash
-KRW 15.67B
Net Cash Per Share
-KRW 740.33
Tangible Book Value Per Share
KRW 4,633.42

Margins

Gross margin is 53.14%, with operating margin of 2.11%, and net profit margin of 1.93%.

Gross Margin
53.14%
Operating Margin
2.11%
Pretax Margin
1.96%
Net Profit Margin
1.93%
EBITDA Margin
3.99%
EBIT Margin
2.11%

Analyst Forecast

The average price target for KUKJE PHARMA Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
5.62%
EPS Growth Forecast
-52.20%

Scores

Smart Score
―
AI Score
62